Familial Cancer

, Volume 5, Issue 4, pp 359–368 | Cite as

Screening behavior in women at increased familial risk for breast cancer

  • Yoland C. Antill
  • John Reynolds
  • Mary Anne Young
  •  ˙ Judy A. Kirk
  • Katherine M. Tucker
  • Tarli L. Bogtstra
  •  ˙ Shirley S. Wong
  •  ˙ Tracy E. Dudding
  • Juliana L. Di Iulio
  • Kelly-Anne Phillips
Original Paper


This multicenter study examined the adherence of high-risk women to screening recommendations for breast and ovarian cancer following consultation at a familial cancer clinic (FCC). Self-report questionnaires assessing recall of screening advice, tests undertaken, risk perception, anxiety (Impact of Events Scale) and demographics were mailed to 396 consecutive eligible women who had attended one of six FCCs a median of 3.6 years prior. Family history, genetic test results and screening recommendations were abstracted from medical records. 182/266 (68.4%) women responded with 130 lost to follow-up. The proportions of women undertaking at least the recommended frequency of screening tests were: breast␣self examination (BSE) 50.4%, clinical breast examination (CBE) 66.0%, mammography 82.2%, transvaginal ultrasound (TVUS) 70.0%, CA125 84.0%. Factors associated with adherence to screening were: higher anxiety for BSE and CBE, being BRCA1/2 positive for CBE, older age, method of arrangement and having at least one affected first degree relative for mammography. Factors significantly associated with over-adherence were higher scores for anxiety for BSE and CBE and younger age (< 40 years) for TVUS. Between 41.3% (BSE) and 57.6% (CBE) of women incorrectly recalled their screening recommendations. A substantial minority of high-risk women do not adhere to screening advice. Strategies to improve the accuracy of recall of recommendations and the uptake of recommended screening are required.


BRCA1 BRCA2 Breast neoplasm Ovarian neoplasm Screening 



Familial Cancer Centre


Breast Self Examination


Clinical Breast Examination


Transvaginal Ultrasound


Breast Cancer


Ovarian Cancer


Carcinoma Intraepithelial Neoplasia


Confidence Interval




Australian Dollars






not applicable


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



We thank Jane Matthews and Bettina Meiser for assistance with protocol development, Geoff Lindeman, Lesley Andrews and Sheridan O’Donnell for data collection and Gillian Mitchell for critical review of an earlier version of the manuscript.


  1. 1.
    Edmondson R, Monaghan JM (2001) The epidemiology of ovarian cancer. Int J Gynecol Cancer 11:423–429CrossRefPubMedGoogle Scholar
  2. 2.
    Sauven P (2004) Guidelines for the management of women at increased familial risk of breast cancer. Eur J Cancer 40:653–665CrossRefPubMedGoogle Scholar
  3. 3.
    Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130CrossRefPubMedGoogle Scholar
  4. 4.
    Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656–1663CrossRefPubMedGoogle Scholar
  5. 5.
    Antill Y, Phillips K (2004) Ovarian cancer screening for high risk women. In: DM G, WP M, M G et al (eds) Gynaecological cancers: Controversies in management. Philadelphia, Elsevier, pp 341–354Google Scholar
  6. 6.
    Brekelmans CT, Seynaeve C, Bartels CC et al (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924–930PubMedGoogle Scholar
  7. 7.
    Dorum A, Kristensen GB, Abeler VM et al (1996) Early detection of familial ovarian cancer. Eur J Cancer 32A:1645–1651CrossRefPubMedGoogle Scholar
  8. 8.
    Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437CrossRefPubMedGoogle Scholar
  9. 9.
    Scheuer L, Kauff N, Robson M et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260–1268CrossRefPubMedGoogle Scholar
  10. 10.
    Tilanus-Linthorst MM, Bartels CC, Obdeijn AI et al (2000) Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer 36:514–519CrossRefPubMedGoogle Scholar
  11. 11.
    Gui GP, Hogben RK, Walsh G et al (2001) The incidence of breast cancer from screening women according to predicted family history risk: does annual clinical examination add to mammography? Eur J Cancer 37:1668–1673CrossRefPubMedGoogle Scholar
  12. 12.
    Burke W, Daly M, Garber J et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer genetics studies consortium. JAMA 277:997–1003CrossRefPubMedGoogle Scholar
  13. 13.
    Eisinger F, Alby N, Bremond A et al (1998) Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee. Ann Oncol 9:939–950CrossRefPubMedGoogle Scholar
  14. 14.
    Kirk J, Tucker K (2000) National best practice guidelines for familial cancer clinics. National Breast Cancer Centre, NHMRCGoogle Scholar
  15. 15.
    Rosen B, Kwon J, Fung Kee Fung M et al (2004) Systematic review of management options for women with a hereditary predisposition to ovarian cancer. Gynecol Oncol 93:280–286CrossRefPubMedGoogle Scholar
  16. 16.
    Familial aspects of cancer: a guide to clinical practice. Canberra, Biotext NHMRC, 1999Google Scholar
  17. 17.
    Familial aspects of ovarian cancer, (in Program) ACNatNBCCitOC (ed): Clinical practice guidelines for the management of women with epithelial ovarian cancer NHMRC, 2004Google Scholar
  18. 18.
    Lerman C, Hughes C, Croyle RT et al (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 31:75–80CrossRefPubMedGoogle Scholar
  19. 19.
    Peshkin BN, Schwartz MD, Isaacs C et al (2002) Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 11:1115–1118PubMedGoogle Scholar
  20. 20.
    Tinley ST, Houfek J, Watson P et al (2004) Screening adherence in BRCA1/2 families is associated with primary physicians’ behavior. Am J Med Genet A 125:5–11CrossRefPubMedGoogle Scholar
  21. 21.
    Botkin JR, Smith KR, Croyle RT et al (2003) Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet A 118:201–209CrossRefPubMedGoogle Scholar
  22. 22.
    Watson M, Foster C, Eeles R et al (2004) Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 91:1787–1794CrossRefPubMedGoogle Scholar
  23. 23.
    Lerman C, Schwartz M (1993) Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat 28:145–155CrossRefPubMedGoogle Scholar
  24. 24.
    Isaacs C, Peshkin BN, Schwartz M et al (2002) Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat 71:103–112CrossRefPubMedGoogle Scholar
  25. 25.
    Meiser B, Butow P, Barratt A et al (2000) Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Res Treat 59:101–111CrossRefPubMedGoogle Scholar
  26. 26.
    Meiser B, Butow P, Barratt A et al (1999) Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 75:122–129CrossRefPubMedGoogle Scholar
  27. 27.
    Tiller K, Meiser B, Gould L et al (2005) Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Psychooncology 14:249–261CrossRefPubMedGoogle Scholar
  28. 28.
    Mann GJ, Thorne H, Balleine RM et al (2006) Analysis of cancer risk and BRCA1 And BRCA2 mutation prevalence in the kConfab familial breast cancer resource. Breast Cancer Res 8:R12CrossRefPubMedGoogle Scholar
  29. 29.
    Evans DG, Burnell LD, Hopwood P et al (1993) Perception of risk in women with a family history of breast cancer. Br J␣Cancer 67:612–614PubMedGoogle Scholar
  30. 30.
    Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41:209–218PubMedGoogle Scholar
  31. 31.
    Thewes B, Meiser B, Hickie IB (2001) Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psychooncology 10:459–468CrossRefPubMedGoogle Scholar
  32. 32.
    StatXact, (ed 5.0.3). Cambridge, MA, Cytel Software Corporation (2001)Google Scholar
  33. 33.
    SAS, (ed 8.2). Cary, NC, SAS Institute (2001)Google Scholar
  34. 34.
    Drescher CW, Nelson J, Peacock S et al (2004) Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening. Cancer Epidemiol Biomarkers Prev 13:600–606PubMedGoogle Scholar
  35. 35.
    Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317–1325CrossRefPubMedGoogle Scholar
  36. 36.
    Warner E, Plewes DB, Shumak RS et al (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19:3524–3531PubMedGoogle Scholar
  37. 37.
    van Dooren S, Rijnsburger AJ, Seynaeve C et al (2003) Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer. Community Genet 6:235–241CrossRefPubMedGoogle Scholar
  38. 38.
    Hailey BJ (1991) Family history of breast cancer and screening behavior: an inverted U-shaped curve? Med Hypotheses 36:397–403CrossRefPubMedGoogle Scholar
  39. 39.
    Kash KM, Holland JC, Halper MS et al (1992) Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84:24–30PubMedGoogle Scholar
  40. 40.
    Lerman C, Kash K, Stefanek M (1994) Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr. 171–176Google Scholar
  41. 41.
    Consedine NS, Magai C, Krivoshekova YS et al (2004) Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev 13:501–510PubMedGoogle Scholar
  42. 42.
    Vasen HF, Tesfay E, Boonstra H et al (2005) Early detection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer 41:549–554CrossRefPubMedGoogle Scholar
  43. 43. Scholar
  44. 44.
    Antill YC, Shanahan M, Phillips KA (2005) The integrated multidisciplinary clinic: A new model for the ongoing management of women at high genetic risk for breast and ovarian cancer. Cancer Forum 29:107–110Google Scholar
  45. 45.
    Zapka JG, Bigelow C, Hurley T et al (1996) Mammography use among sociodemographically diverse women: the accuracy of self-report. Am J Public Health 86:1016–1021PubMedGoogle Scholar
  46. 46.
    Caplan LS, McQueen DV, Qualters JR et al (2003) Validity of women’s self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev 12:1182–1187PubMedGoogle Scholar
  47. 47.
    Montano DE, Phillips WR (1995) Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J␣Public Health 85:795–800PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • Yoland C. Antill
    • 1
    • 3
  • John Reynolds
    • 2
  • Mary Anne Young
    • 1
  •  ˙ Judy A. Kirk
    • 4
  • Katherine M. Tucker
    • 5
  • Tarli L. Bogtstra
    • 6
  •  ˙ Shirley S. Wong
    • 7
  •  ˙ Tracy E. Dudding
    • 8
  • Juliana L. Di Iulio
    • 2
  • Kelly-Anne Phillips
    • 1
    • 3
  1. 1.Department of Hematology and Medical OncologyPeter MacCallum Cancer CentreMelbourneAustralia
  2. 2.Statistical Centre, Peter MacCallum Cancer Centre, Locked Bag1, A'Beckett StMelbourneAustralia
  3. 3.University of MelbourneMelbourneAustralia
  4. 4.Westmead HospitalWestmeadAustralia
  5. 5.Prince of Wales HospitalRandwickAustralia
  6. 6.Monash Medical CentreClaytonAustralia
  7. 7.Royal Melbourne HospitalParkvilleAustralia
  8. 8.Hunter GeneticsNewCastleAustralia

Personalised recommendations